2019年11月13日 · CMML-2 is characterized by 10-19% bone marrow myeloblasts and/or 5-19% peripheral blood myeloblasts. However, whether this represents a distinct clinical entity or a …

CMML-2, for cases with 5 to 19 percent blasts in the blood and 10 to 19 percent blasts in the bone marrow; Most healthy individuals have less than 5 percent blast cells in their developing bone …

Chronic myelomonocytic leukemia (CMML) is a type of cancer that starts in blood-forming cells of the bone marrow and invades the blood. It affects mainly older adults. If you’ve just been …

Chronic myelomonocytic leukemia (CMML) is a myelodysplastic syndrome/myeloproliferative overlap neoplasm characterized by sustained peripheral blood monocytosis and an inherent …

CMML is also classified as being "myeloproliferative (MP-CMML)" or "myelodysplastic (MD-CMML)," based on the presence or absence of leukocyte count of ≥13 × 10 9 /L. Treatment: …

Chronic myelomonocytic leukemia (CMML) is a rare type of blood cancer. It starts in blood-forming cells in the bone marrow. CMML is slow growing, but over time the leukemia cells can …

CMML - 2 means you have 5 -19% blast cells in your blood and 10-19% in your bone marrow. Knowing your type of CMML, along with other factors, helps your doctor to decide on your risk …

Chronic myelomonocytic leukemia (CMML) is cancer of the blood. CMML is considered to be one of the myeloproliferative neoplasms (MPNs), a type of chronic blood cancer in which a …

Chronic myelomonocytic leukemia (CMML) is a clonal disorder of hematopoietic cells and is a complex of heterogeneous conditions with both myeloproliferative and myelodysplastic …

慢性粒单核细胞白血病（cmml）是临床上很少见的一种血液病，其临床表现、生存期、血常规检查具有多样性。 多数在60岁以后发病，CMML具有明显的病态造血，造血功能多数较差。